Clinical trial
Interferon-Alpha for Diabetes Mellitus Type 1
NCT00024518 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00024518 |
|---|---|
| Title | Interferon-Alpha for Diabetes Mellitus Type 1 |
| Official title | Ingested Interferon-Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Diabetes Mellitus |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Insulin-Dependent Diabetes Mellitus |
| Intervention type | Drug, Other |
| Interventions | 30, 000 units hrINF-alpha, 5, 000 hrINF-alpha, Placebo |
| Enrollment | 57 |
| Start date | Sep 1, 2001 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Sep 19, 2001 |
| Last update posted | Nov 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: